Lv11
40 积分 2025-08-01 加入
Phased Variant–Supported Circulating Tumor DNA as a Prognostic Biomarker After First-Line Treatment in Large B-Cell Lymphoma: Findings From the DIRECT Study
5小时前
已完结
Integrated prognostic value of MRD and cytogenetics in adolescent and adult B‐cell acute lymphoblastic leukaemia
1个月前
已完结
Concordance of Next-Generation Sequencing and Multiparametric Flow Cytometry Methods for Detecting Measurable Residual Disease in Adult Acute Lymphoblastic Leukemia: Optimizing Prediction of Clinical Outcomes From a Single-Center Study
8个月前
已完结
Minimal Residual Disease–Based End Point for Accelerated Assessment of Clinical Trials in Multiple Myeloma: A Pooled Analysis of Individual Patient Data From Multiple Randomized Trials
11个月前
已完结
Optimal MRD-based end point to support response-adapted treatment cessation in newly diagnosed multiple myeloma
11个月前
已完结
皖公网安备34019202002308
